Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)

Last updated: November 10, 2023
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Testicular Cancer

Germ Cell Tumors

Cancer/tumors

Treatment

N/A

Clinical Study ID

NCT06133036
Soh-Med-23-10-10MS
  • Ages 3-18
  • All Genders

Study Summary

Sacrococcygeal teratoma is one of the most common tumors that occur in the neonatal period. It presents either as a mass protruding from the sacrococcygeal region or as a pelviabdominal mass according to the type. Surgical excision is the main treatment, most masses are benign, however some are malignant and require radiotherapy or chemotherapy. Complications may occur due to pressure resulting from the tumor growth in the fetal period, or due to damage to important near tissues during surgical excision. Postoperative complications may be urinary as neurogenic bladder, Lower gastrointestinal as constipation, soiling or incontinence. In this work we study the outcomes of fecal continence through a questionnaire and its effect on the quality of life of the affected children.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • all patients with sacrococcygeal teratoma operated after july 2010 and older than 3years old.

Exclusion

Exclusion Criteria:

  • Patients lost to follow up before 6 months after surgery.
  • Patients with Currarino triad.

Study Design

Total Participants: 20
Study Start date:
November 01, 2023
Estimated Completion Date:
May 31, 2024

Connect with a study center

  • Sohag University Hospitals

    Sohag, 82511
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.